DIRECTORS' REPORT

Your directors have the pleasure in presenting the Thirty-First (31^st) Annual Report of the Company for the year ended
March 31, 2026.

FINANCIAL PERFORMANCE

A summary of the Company’s financial performance for the year is provided below:

(Amount ' in Lakh)

1. REVIEW OF BUSINESS OPERATIONS

Your directors are pleased to present the Financial
Report for year ended March 31, 2026.

The year under review has remained very eventful
creating strong growth base for your Company.
Significant events as under:

a) IPO and Listing

Amanta Healthcare Limited launched a fresh issue
of 1 crore equity shares, totaling ^126 crore, and
successfully got its equity shares listed & traded
on the National Stock Exchange of India Limited
(NSE) and BSE Limited (BSE) with effect from
September 9, 2025.

b) Preference Shares Redemption:

As part of its capital restructuring, the company
redeemed preference shares during this period,
aimed at simplifying the capital structure post-IPO.

c) Expansion Projects:

The company is implementing major capital
expenditure utilizing IPO proceeds to set up
new manufacturing lines for SteriPort (approx.
^ 90 crore) and Small Volume Parenterals (SVP)
(approx. ^30.13 crore) at its facility in Hariyala,
Dist.- Kheda, Gujarat.

The Steriport project is currently at completion
stage and commercial operations expected by
Sept 2026. The SVP line is targeted for completion
during Q4 2027.

d) Solar initiative for Cost Optimization:

To improve operational efficiency and reduce energy
costs, Amanta Healthcare Limited has set up a 10.8
MW captive solar power plant. Generation from the
plant has already started from June 2026.

The investment is part of the company’s ESG
(Environmental, Social, and

Governance) initiatives and is specifically
intended to optimize operational costs by

reducing electricity expenses.

As far as the operations are concerned, as
company is operating at full capacity the turnover
of the company for the year ended 31^st March,
2026 has remained stable. Company has achieved
turnover of ' 28767.67 lakhs for FY 26 against
' 27471 lakhs for FY 25.

Domestic demand for our product is robust.
At the same time Company aims to increase
export business significantly creating a strong
base for future.

2. CHANGES IN SHARE CAPITAL OF THE
COMPANY

Authorized Share Capital

The authorized share capital of the Company
remains unchanged at ^. 90,15,00,000 comprising
of 8,01,50,000 equity shares of ^10 each and
1,00,00,000 preference shares of ' 10 each.

Paid-Up Share Capital

The paid-up share capital of the Company has
been increased from 28,82,93,510 comprising of
2,88,29,351 equity shares of =? 10 each to 38,82,93,510
comprising of 3,88,29,351 equity shares of ^ 10 each,
pursuant to shares allotted on account of Initial Public
Offering during the year.

Redemption of Preference Shares (RPS)

The Company has redeemed 1,00,00,000 redeemable
preference shares of ^10 each, which were issued on
30^th March, 2022.

The redemption was carried out on 29^th September,
2025 at a premium of ^11.742 per RPS, out of the
distributable profits of the Company, in accordance
with the provisions of Section 55 of the Companies Act,
2013 and the terms of issue authorized by the Articles
of Association.

An amount equal to the nominal value of RPS i.e., ^
10,00,00,000 (Rupees Ten Crores only), has been
transferred to the Capital Redemption Reserve (CRR)
Account from the balance of distributable profits
available in the Statement of Profit and Loss, in
accordance with the provisions of the Act.

Initial Public Offering

Amanta Healthcare Limited a leading player in
the field of wide variety of large and small volume
preparations in sterile dosage forms, has initiated
its Initial Public Offering (IPO), marking a pivotal
development in its over three-decade-long corporate
journey. Incorporated in 1994 and headquartered in
Ahmedabad, Amanta Healthcare Limited has grown into
a significant provider of sterile liquid and have geared its
production facility to become a versatile manufacturer.

The IPO comprised of 1,00,00,000 Equity Shares of face
value of ^10 per equity share at an issue price of ^126
per equity share (including a premium of ^116 per equity
share). The primary purpose of the fresh issue was to fund
capital expenditure for setting up new manufacturing
line of SteriPort and SVP at Hariyala, Kheda, Gujarat, and
support general corporate purposes.

The offer also included provisions for participation by
qualified institutional buyers (QIBs), non-institutional
investors (NIIs), and retail individual investors (RIIs),
in accordance with SEBI regulations. NSE has been
designated as the lead stock exchange for the issue.

Amanta Healthcare Limited made a stellar debut on
the National Stock Exchange of India Limited (NSE)
and BSE Limited (BSE) on 9^th September, 2025.
Following the listing, the shares of the Company are
traded in electronic form under the symbol: [NSE
Trading Symbol: AMANTA & BSE Scrip Code:544502]”.

The Company is regular in payment of Annual Listing
Fees. The Company has paid Listing fees up to
the year 2026-27.

3. REPORT ON THE UTILISATION OF PROCEEDS
OF THE INITIAL PUBLIC OFFER RAISED
DURING THE FINANCIAL YEAR 2025-26

The Company has appointed ‘CRISIL Ratings Limited’
as the monitoring agency to monitor the utilization of
the issue proceeds from the Initial Public offer of the
Company raised during the financial year 2025-26.

The Monitoring agency duly submit its report on a
quarterly basis to the Audit Committee and the Board of
Directors. The Audit Committee and Board of Directors
duly took note of the same and filed it with the stock
exchange as required under Regulation 32(6) of the
SEBI (Listing Obligations & Disclosure Requirements)
Regulations, 2015.

During the quarter ended September 30, 2025, net
proceeds have been revised from ' 10,673.57 lakhs to
' 10,315.19 lakhs, on account of actual issue expenses
being higher than estimated as disclosed in the
Prospectus, by ' 358.38 lakhs and the same has been
adjusted with General corporate purposes.

4. RESERVES

Your Company does not propose to transfer any amount
to general reserve.

5. ANNUAL RETURN

In terms of Section 92(3) of the Companies Act, 2013
and Rule 12 of the Companies (Management and
Administration) Rules, 2014, the Annual Return of the
Company is available on the website of the Company
and may be accessed through www.amanta.co.in.

6. DIRECTORS RESPONSIBILITY STATEMENT

In accordance with the provisions of Section 134(5) of
the Companies Act, 2013 your Directors confirm to the
best of their knowledge and belief that:

a) In the preparation of the annual accounts, the
applicable accounting standards had been
followed along with proper explanation relating to
material departures;

b) The Directors had selected such accounting
policies and applied them consistently and made
judgments and estimates that are reasonable
and prudent so as to give a true and fair view of
the state of affairs of the company at the end of
financial year and of the profit and loss of the
company for that period.

c) The Directors had taken proper and sufficient
care for the maintenance of adequate accounting
records in accordance with the provisions of this
Act for safeguarding the assets of the company
and for preventing and detecting fraud and other
irregularities;

d) The Directors had prepared the annual accounts
on a going concern basis;

e) The directors, had laid down internal
financial controls to be followed by the company
and that such internal financial controls are
adequate and operating effectively; and

f) The Directors had devised proper systems to
ensure compliance with the provisions of all
applicable laws and that such systems were
adequate and operating effectively.

7. DIRECTORS AND KEY MANAGERIAL
PERSONNELS

Board of Directors

The composition of the Board of Directors of the
Company is in accordance with the provisions of
Section 149 of the Act and Regulation 17 of the Listing
Regulations, with an appropriate combination of
Executive, Non-Executive, and Independent Directors.
The Board of the Company has 6 (Six) Directors
comprising of 1 (One) Managing Director, 2 (Two)
Non-Executive Directors, and 3 (Three) Independent
Directors (including a Woman Director). The complete
list of Directors of the Company along with their brief
profile has been provided in the Report on Corporate
Governance forming part of this Annual Report.

Further, all the Directors and senior management
personnel of the Company affirmed compliance with
the Code of Conduct for the financial year 2025-2026
and the declaration in this respect appears elsewhere
in the Annual Report.

In accordance with the provisions of Section 152 and
other applicable provisions, if any, of the Companies
Act, 2013 and the Articles of Association of the
Company, Mr. Nimesh P Patel, Non-executive Director
is liable to retire by rotation at the ensuing 31^st AGM and
being eligible, has offered himself for re-appointment.
Company has not received any amount from a director
or a relative of the director of the Company, as deposit
or otherwise, during the year under review.

Key Managerial Personnels

As on the date of this report, the following are Key
Managerial Personnels (“KMPs”) of the Company as per
Sections 2(51) and 203 of the Companies Act, 2013:

1. Shri Bhavesh Girishbhai Patel, Managing Director,

2. Shri Shailesh Shah, Chief Financial Officer (up
to May 17, 2025)

2. Shri Paras Mehta, Chief Financial Officer (from
May 26, 2025) and

3. Ms. Nikhita Dinodia, Company Secretary and
Compliance officer

During the FY 2025-26, Shri Shailesh Shah ceased to be
KMP on account of his resignation w.e.f May 17, 2025.

Further, Shri Paras Mehta was appointed as Chief
Financial Officer with effect of 26^th May, 2025.

Independent Directors

The Independent Directors had submitted their
disclosures to the Board that they fulfil the requirements
as stipulated under Section 149(6) of the Act and
Regulation 25(8) of Listing Regulations. There had
been no change in the circumstances affecting their
status as Independent Directors of the Company to
qualify themselves to be appointed as Independent
Directors under the provisions of the Act and the
relevant regulations. The Independent Directors have
given the declaration under Rule 6(3) of the Companies
(Appointment and Qualification of Directors) Rules,
2014 confirming compliance with Rule 6(1) and (2)
of the said Rules that their names are registered in
the databank as maintained by the Indian Institute of
Corporate Affairs (“IICA”).

In the opinion of the Board, Mr. Kshitij Manubhai
Patel, Mr. Nitin Jain and Ms. Anjali Nirav Choksi are
persons of integrity and fulfils requisite conditions
as per applicable laws and are independent of the
management of the Company.

During the year under review, the Independent
Directors of the Company had no pecuniary relationship
or transactions with the Company, other than sitting
fees, and reimbursement of expenses, if any.

Shri Nitin Jain, Independent Director, holds 1 equity shares
of the Company, Smt. Dympal Jain, wife of Shri Nitin Jain
(Independent Director) holds 15,676 equity shares of
the Company, and Ms. Anjali Nirav Choksi, Independent
Director, holds 1500 equity shares of the Company during
the financial year ended 31^st March, 2026.

The Board is of the view that Mr. Kshitij Manubhai Patel,
Mr. Nitin Jain and Ms. Anjali Nirav Choksi possess
adequate integrity, expertise (including the proficiency)
and experience for the effective and efficient discharge
of duties of Independent Directors.

Separate meeting of Independent Directors

During the year under review, a separate meeting of
Independent Directors of the Company was held on
22^nd August, 2025 and 16^th March, 2026 to consider:

I. Recommendation of the price band in relation to
the public offer;

II. the Performance evaluation of Chairperson,
Non-Independent Directors and the Board
as a whole; and

III. assess the quality, quantity and timeliness of flow of
information between the Company’s Management
and the Board that is necessary for the Board to
effectively and reasonably perform their duties.

Committees of the Board

During the year 2025-26, in compliance with the
SEBI listing regulations, the Company has constituted
mandatory committees as mentioned below.

9. PERFORMANCE EVALUATION OF THE BOARD,
BOARD COMMITTEES, AND DIRECTORS

The Company has adopted the Board Evaluation
Framework and Policy based on the recommendation
of the Nomination and Remuneration Committee (NRC),
which sets a mechanism and criteria for performance
evaluation of the Board, Board Committees and
Directors, including Independent Directors.
The same is available at the website of the Company
www.amanta.co.in.

The performance of the Board, the Committees and
individual Directors was evaluated by the Board
after seeking inputs from all the Directors through a
questionnaire wherein the Directors evaluated the
performance on scale of one to ten based on the
following criteria:

a) Criteria for Board performance evaluation includes
degree of fulfilment of key responsibilities, Board
structure and composition, establishment, and
delineation of responsibilities to committees,
effectiveness of board processes, information
and functioning, board culture and dynamics,
quality of relationship between the Board and
the management.

b) Criteria for Committee performance evaluation
includes degree of fulfilment of key responsibilities,
adequacy of committee composition, effectiveness
of meetings, committee dynamics, quality of
relationship of the committee with the Board, and
the management.

c) Criteria for performance evaluation of Individual
Directors includes fulfilment of the independence
criteria as specified in the Listing Regulations
and their independence from the management,
attendance, contribution at meetings, guidance,
support to management outside Board/
Committee meetings.

The above criteria are broadly based on the Guidance
Note on Board Evaluation issued by the Securities and
Exchange Board of India on January 5, 2017.

The NRC also reviewed the performance of the individual
directors. In a separate meeting of Independent
Directors, performance of Non-Independent Directors
and performance of the Board was evaluated, views of

the Non-Executive Directors were also taken.

The Board and the NRC reviewed the performance of
individual Directors on the basis of criteria such as the
contribution of the individual Directors to the Board and
Committee meetings like preparedness on the issues to
be discussed, meaningful and constructive contribution
and inputs in meetings, etc.

In the Board meeting that followed the meeting of
the Independent Directors and meeting of NRC,
the performance of the Board, its committees and
individual directors were also discussed.

Performance evaluation of Independent Directors was
done by the entire Board, excluding the Independent
Director being evaluated.

10. NET WORTH OF THE COMPANY

The Net Worth of the Company as on 31^st March 2026 is
' 22021.10 Lakhs as compared to ' 9638.83 Lakhs as
on 31^st March, 2025.

11. PARTICULARS OF LOANS, GUARANTEES OR
INVESTMENTS

As at 31^st March, 2026, the Company has no inter¬
corporate loans, guarantees, investments or security
as specified in Section 186 of the Act.

12. RELATED PARTY TRANSACTIONS

The Company has a Policy on Materiality of Related
Party Transactions and on dealing with Related Party
Transactions, in accordance with the Companies Act,
2013 and the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements)
Regulations, 2015. This Policy is disclosed on the
website of the company and may be accessed through
www.amanta.co.in.

During the financial year under consideration, all
contracts / transactions entered into by the Company
with related parties were in the ordinary course of
business and on arm’s length basis. The Company
has not entered into any contract / arrangement /
transaction with related party(ies) which may be
termed as material in nature and not executed in
ordinary course of business and not on arm’s length
basis. Hence, details are not required to be furnished in
Form AOC-2 as “Annexure-1”.

13. DIVIDEND AND DIVIDEND DISTRIBUTION
POLICY

The Board of Directors of the Company (“Board”), after
considering the relevant circumstances holistically and
keeping in view the Company’s Dividend Distribution
Policy, has decided that it would be prudent not to
recommend any dividend for the year under review.

In compliance with Regulation 43A of the Securities
and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the
Company has Dividend Distribution Policy in place.
This policy is disclosed on the website of the Company
and may be accessed through www.amanta.co.in.

14. TRANSFER OF UNCLAIMED DIVIDEND TO
INVESTOR EDUCATION AND PROTECTION FUND

There were no amounts which were required to be
transferred to the Investor Education and Protection
Fund by the Company during the year ended
March 31, 2026.

15. MATERIAL ORDER PASSED BY REGULATORS

No significant or material orders were passed by the
Regulators or Courts or Tribunals which impact the going
concern status and Company’s operations in future.

16. THE DETAILS OF APPLICATION MADE OR
ANY PROCEEDING PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016

Neither application was made nor any
proceeding is pending under the Insolvency and
Bankruptcy Code, 2016.

17. MATERIAL CHANGES AND COMMITMENTS,
AFFECTING THE FINANCIAL POSITION OF THE
COMPANY

No material changes and commitments affecting the
financial position of the Company occurred between
the end of the financial year to which these financial
statements relate and the date of this Report.

18. THE DETAILS OF DIFFERENCE BETWEEN
AMOUNT OF THE VALUATION DONE AT THE
TIME OF ONE TIME SETTLEMENT AND THE
VALUATION DONE WHILE TAKING LOAN FROM
THE BANKS OR FINANCIAL INSTITUTIONS
ALONG WITH THE REASONS THEREOF

No settlements have been done with banks or
financial institutions.

19. CONSERVATION OF ENERGY AND TECHNOLOGY
ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO

The information pertaining to conservation of energy,
technology absorption, foreign exchange Earnings
and outgo as required under Section 134(3)(m) of
the Companies Act, 2013 read with Rule 8(3) of the
Companies (Accounts) Rules, 2014 forms part of this
report and is given by way of “Annexure- 2”.

20. RISK MANAGEMENT

The Company has put in place a Risk Management
Policy to define a framework for identification,
assessment, categorization and treatment of risks
and selecting appropriate risk management approach.
The Company’s outlook in dealing with various risks
associated with the business includes the decision on
acceptance of risks, avoidance of risks, transfer of risks
and risks tolerance level.

This Policy is disclosed on the website of the company
and may be accessed through www.amanta.co.in.

21. INTERNAL CONTROL SYSTEM AND ITS
ADEQUACY

The Company has effective internal control system in
place, which ensures that all the assets of the Company
are safeguarded and protected against any loss from
unauthorized use or disposition. The Company has
also put in place adequate internal controls with
reference to the financial statements commensurate
with the size and nature of operations of the Company.
Such controls were tested and test results summary of
the testing done based on key controls shown effective
controls prevailing within the Company during the
year under review.

Internal auditor of the Company also periodically
carry out review of the internal control system and
procedures and their reports are placed before Audit
Committee for review. There were no significant
comments / findings in the reports of Internal auditor
during the year under review.

22. CORPORATE SOCIAL RESPONSIBILITY
COMMITTEE

In compliance with the requirements of Section 135
of the Companies Act, 2013 (‘the Act’) read with the
Companies (Corporate Social Responsibility Policy)
Rules, 2014 (CSR Rules), the Board of Directors
have constituted a Corporate Social Responsibility
Committee. Annual Report on CSR containing
particulars specified in Annexure II to the CSR Rules is
forming part of the Board’s Report as per “Annexure 3”.

The contents of the CSR Policy of the Company as
approved by the Board on the recommendation of the
Corporate Social Responsibility Committee and other
details are available on the website of the Company and
may be accessed through www.amanta.co.in.

23. POLICY ON DIRECTOR’S APPOINTMENT AND
REMUNERATION

Nomination Policy acts as a guideline for determining
qualifications, positive attributes, independence of
Directors and matters related to the appointment and
removal of Directors and Senior Management.

Remuneration Policy lays down the Company’s
philosophy and criteria as well as manner of determining
the remuneration of Managing Director, Executive/

Non-Executive Directors, Independent Directors,
Senior Management, Key Managerial Personnel and
other employees.

The Board has, on the recommendation of the
Nomination and Remuneration Committee, approved
a policy for selection and appointment of Directors,
Key Managerial Personnel, Senior Management and
for determining their remuneration. The Policy of the
Company on directors’ appointment and remuneration,
including the criteria for determining qualifications,
positive attributes, independence of a director and
other matters, as required under sub-section (3) of
Section 178 of the Companies Act, 2013, is available
on Company’s website and accessible through
www.amanta.co.in.

24. VIGIL MECHANISM/WHISTLE BLOWER POLICY

The Company has in place Vigil Mechanism/ Whistle
Blower Policy. It lays down a mechanism for reporting
and investigation of all unethical behaviour, alleged
or potential violations of laws, regulations or Code of
Conduct, policies, procedures or other standards.

Employees have numerous ways to voice their concerns
and are encouraged to report the same internally
for resolution. The said Policy provides for adequate

27. SUBSIDIARIES, JOINT VENTURES AND
ASSOCIATE COMPANIES

The Company does not have any Subsidiary, Joint
venture or Associate Company.

Company have also framed a policy for determining
“material” subsidiaries and the same is available
on Company’s website and accessible through
www.amanta.co.in.

28. DEPOSITS

The Company has neither accepted nor renewed any
deposits during the year. The Company does not have
any deposits outstanding as at 31^st March, 2026.

29. INSURANCE

The Company’s properties including building, plant and
machinery, stocks, stores, etc. continue to be adequately
insured against risks such as fire, riot, strike, civil
commotion, malicious damages, earthquake, flood, etc.

safeguards against retaliation and access to the
Chairperson of the Audit Committee.

The Whistle Blower Policy is available on Company’s
website and accessible through www.amanta.co.in.

25. CODE FOR PREVENTION OF INSIDER TRADING

Company has adopted a Code of Conduct (“Code”)
to regulate, monitor and report trading in Company’s
shares by Company’s designated persons and their
immediate relatives as per the requirements under the
Securities and Exchange Board of India (Prohibition of
Insider Trading) Regulations, 2015.

The Code, inter alia, lays down the procedures to be
followed by designated persons while trading/ dealing
in Company’s shares and sharing Unpublished Price
Sensitive Information (“UPSI”). The Code covers the
Company’s obligation to maintain a digital database,
mechanism for prevention of insider trading and
handling of UPSI, and the process to familiarize with
the sensitivity of UPSI. Further, it also includes code
for practices and procedures for fair disclosure of
unpublished price sensitive information which has
been made available on the Company’s website
www.amanta.co.in.

30. AUDITORS

Statutory Auditor

M/s Price Waterhouse Chartered Accountants LLP,
with Firm Registration Number 012754N/N500016,
have been re-appointed as Statutory Auditor of
the Company to hold office for a further period of
5 Years commencing from the conclusion of 27^th
Annual General Meeting until the conclusion of
the 32^nd Annual General Meeting of the Company.
The observations of the Auditors in their report on
Accounts and the Financial Statements, read with
the relevant notes are self-explanatory. The Audit
Report does not contain any qualification, reservation,
adverse remark, or disclaimer.

Further, Statutory Auditor have confirmed their eligibility
under Section 141 of the Companies Act, 2013 and the
Rules framed there under.

Cost Auditor

As per the requirements of the Section 148 of the
Act read with the Companies (Cost Records and
Audit) Rules, 2014 as amended from time to time,
the Company is required to maintain cost records and
accordingly, such accounts are made and records have
been maintained every year.

The Board has appointed, M/s. Y.S. Thakar & Co.
(FRN: 000318), Cost Accountants, as the Cost Auditor
to conduct the audit of the Cost Records of the Company
for the Financial Year ended March 31, 2026.

Pursuant to Section 148 of the Companies Act,
2013 read with The Companies (Cost Records and
Audit) Amendment Rules, 2014, the Directors on the
recommendation of the Audit Committee, re-appointed
M/s Y.S. Thakar & Co., Cost Accountants, to audit the
Cost Accounts of the Company for the Financial Year
ending March 31, 2027 on a remuneration of ' 75,000
plus GST & out of pocket expenses.

As required under the Companies Act, 2013, the
remuneration payable to the Cost Auditor is required
to be placed before the Members in a general meeting
for their ratification. Accordingly, a resolution seeking
Member’s ratification for the remuneration payable
to M/s. Y.S. Thakar & Co., Cost Accountants for the
Financial Year ending March 31, 2027, is proposed in
the Notice convening the Annual General Meeting.

Cost Audit Report

As per the provisions of Section 148(1) of the
Companies Act, 2013, the Company has maintained the
cost records, as specified by the Central Government.
The Cost Audit Report for the financial year does not
contain any qualification(s), reservation(s) or adverse
remark(s) or disclaimer.

Internal Auditor

M/s. Parikh Shah & Associates, Chartered Accountants,
(Firm Registration No. 123999W) are the Internal
Auditors of the Company for the financial year 2026¬
27. Further, M/s. Parikh Shah & Associates, Chartered
Accountants are reappointed as Internal Auditors of the
Company for the financial year 2026-27.

Internal Audit Report, their significant observations and
follow up actions taken by the Management is reviewed
by the Audit Committee.

Secretarial Auditor

The Secretarial Audit Report for the financial year
ended March 31, 2026, is annexed as “Annexure-4”
and forms an integral part of this Annual Report.

During the period under review, the Company has
complied with the provisions of the Act, Rules,
Regulations, Guidelines, Standards etc. covered under
the Secretarial Audit. The Secretarial Audit Report

does not contain any qualification, reservation, or
adverse remark.

The Board has appointed M/s Kashyap R. Mehta &
Partners, a firm of Practising Company Secretaries to
conduct Secretarial Audit of the Company for a period
of 5 year from the financial year 2026-27 till the FY
2030-31 subject to approval of members/shareholders
pursuant to Regulation 24A of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015.

Auditor’s Report and Secretarial Audit Report

The observations of the Auditors in their report on
Accounts and the Financial Statements, read with the
relevant notes are self-explanatory. The Audit Report
does not contain any qualification, reservation, adverse
remark, or disclaimer.

In terms of Section 204 of the Companies Act, 2013
and Regulation 24A of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015,
a Secretarial Audit Report given by the Secretarial
Auditors in Form No. MR-3 is annexed with this Report.
There are no qualifications, reservations or adverse
remarks made by Secretarial Auditors in their Report.

31. FRAUDS REPORTED BY THE AUDITORS

There was no instance of fraud during the year under
review, which required the Statutory Auditors to
report to the Audit Committee and / or to the Board as
required under Section 143(12) of the Act and the rules
made thereunder.

32. REPORT ON CORPORATE GOVERNANCE

The Company is committed to adhere to the Corporate
Governance requirements as stipulated under the
Companies Act, 2013 read with the rules and regulations
issued by the Securities and Exchange Board of India.
Report on Corporate Governance for the financial year
under review, and a certificate regarding compliance
with the conditions of Corporate Governance are
appended to the Annual Report as “Annexure - 5”.

33. PREVENTION OF SEXUAL HARRASMENT AT
WORKPLACE

As per the requirement of The Sexual Harassment
of Women at Workplace (Prevention, Prohibition &
Redressal) Act, 2013 and rules made thereunder,
the Company has laid down a Prevention of Sexual
Harassment (POSH) Policy and has constituted
Internal Committees (ICs), to consider and resolve
the complaints related to sexual harassment. The ICs
includes external members with relevant experience
and a senior women as presiding officer. Company has
zero tolerance on sexual harassment at the workplace.
The ICs also work extensively on creating awareness on
relevance of sexual harassment issues. The employees
are required to undergo a mandatory training/
certification on POSH to sensitize themselves and
strengthen their awareness.

34. STATEMENT BY THE COMPANY WITH RESPECT
TO THE COMPLIANCE TO THE PROVISIONS
RELATING TO THE MATERNITY BENEFITS ACT,
1961

This is to certify that Amanta Healthcare Limited is fully
compliant with the provisions of the Maternity Benefit
Act, 1961, as amended from time to time.

The Company ensures the following in
accordance with the Act:

Maternity Leave: Female employees are granted
maternity leave of 26 weeks (for the first two
children) with full wages, as per Section 5 of the
Act. For subsequent children, 84 days of maternity
leave is provided.

Payment of Maternity Benefit: Eligible women
employees are paid maternity benefit at the rate of
the average daily wage for the period of their actual
absence from duty.

Medical Bonus: An amount of '3500/- will be paid one
time “Medical Bonus” once employee resumes duty.

Prohibition of Dismissal: No woman employee is
dismissed or discharged on account of her absence
due to maternity leave, and all benefits are preserved
during such leave.

Awareness and Support: The Company actively
informs and supports its female employees about their
rights and entitlements under the Act.

Your Company is committed to safeguarding the rights
of its female employees and maintaining a workplace
that is compliant with all applicable labour laws.

35. DISCLOSURE UNDER SECTION 197(12)
OF THE COMPANIES ACT, 2013 AND
OTHER DISCLOSURES AS PER RULE 5
OF THE COMPANIES (APPOINTMENT
AND REMUNERATION OF MANAGERIAL
PERSONNEL) RULES, 2014

Disclosures required in accordance with the provisions
of Section 197(12) of the Act, read with Rule 5(1) of
the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014, forms part of this
Report. However, as per the provisions of Sections 134
and 136 of the Companies Act, 2013, the Report and
Financial Statements are being sent to the Members
and others entitled thereto, excluding the Statement
containing Particulars of Employees, which is available
for inspection by the Members up to the date of ensuing
Annual General Meeting. Any Member interested in
obtaining a copy of such Statement may write to the
Company Secretary atcs@amanta.co.in.

PARTICULARS OF EMPLOYEES:

There is no Employee drawing remuneration requiring
disclosure under Rule 5(2) of Companies (Appointment
& Remuneration of Managerial personnel) Rules, 2014.

36. ENVIRONMENT, HEALTH AND SAFETY

The Company is committed to health and safety of its
employees, contractors and visitors. We are pleased
to say that we are compliant of Environmental,
Health & Safety (EHS) Regulations stipulated under
the Water (Prevention and Control of Pollution) Act,
The Air (Prevention and Control of Pollution) Act, The
Environment Protection Act and other applicable
Industrial Laws. Our mandate is not to comply but
to go beyond compliance standards, and we are
progressive in this direction. The health and safety of
our people is paramount. We prepare our people as
much as possible for the potential risks in our facilities.
This preparation includes adherence to clear standards,
education, training, auditing and follow-up to reinforce
accountability.

37. DEMATERIALIZATION OF EQUITY SHARES

Shareholders have an option to dematerialise their
shares with either of the depositories viz NSDL and
CDSL. The ISIN No. allotted is INE084k01015.

38. SECRETARIAL STANDARDS

The Company has complied with the applicable
provisions of Secretarial Standards 1 and 2 issued
by the Institute of Company Secretaries of India and
notified by the Ministry of Corporate Affairs.

39. OTHER DISCLOSURES

The Directors state that no disclosure or reporting
is required in respect of the following items, as there
were no transactions/events of these nature during the
year under review:

• Significant or material orders passed by the
Regulators or Courts or Tribunals which impact
the going concern status and the Company’s
operation in future;

• Issue of equity shares with differential rights as to
dividend, voting or otherwise;

• Issue of sweat equity shares to directors
or employees;

• Issue of bonus shares or ESOPs to employees
of the Company;

• One time settlement of loan obtained from the
Banks or Financial Institutions.

40. CAUTIONARY STATEMENT

Statements in the Annual Report, including those
which relate to Management Discussion and Analysis
describing the Company’s objectives, projections,
estimates and expectations, may constitute ‘forward
looking statements’ within the meaning of applicable
laws and regulations. Although the expectations
are based on reasonable assumptions, the actual
results might differ.

41. ACKNOWLEDGEMENTS

The Directors are highly grateful for all the guidance,
support and assistance received from the Government
of India, Governments of various states in India,
concerned Government departments, Financial
Institutions and Banks. The Directors thank all the
esteemed shareholders, customers, suppliers and
business associates for their faith, trust and confidence
reposed in the Company

The Directors wish to place on record their sincere
appreciation for the dedicated efforts and consistent
contribution made by the employees at all levels, to
ensure that the Company continues to grow and excel.

For and on behalf of the Board
Bhavesh Girishbhai Patel

Place: Ahmedabad, Gujarat Chairman & Managing Director

Date: 5^th August, 2026 DIN: 00085505